Publications
Found 1 results
Filters: Author is D.M. Fan [Clear All Filters]
“Screening and identification of peritoneal metastasis-related genes of gastric adenocarcinoma using a cDNA microarray”, vol. 11, pp. 1682-1689, 2012.
,
Arboleda MJ, Lyons JF and Kabbinavar FF (2003). Overexpression of AKT2/protein kinase Bh leads to up-regulation of h1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 63: 196-206.
PMid:12517798
Bai F, Liang J, Wang J, Shi Y, et al. (2007). Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. J. Mol. Med. 85: 169-180.
http://dx.doi.org/10.1007/s00109-006-0115-8
PMid:17043801
Brito M, Malta-Vacas J, Carmona B, Aires C, et al. (2005). Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility. Carcinogenesis 26: 2046-2049.
http://dx.doi.org/10.1093/carcin/bgi168
PMid:15987717
Cho YG, Nam SW, Kim TY, Kim YS, et al. (2003). Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 111: 539-545.
http://dx.doi.org/10.1034/j.1600-0463.2003.1110502.x
PMid:12887505
Choi MG, Sung CO, Noh JH, Kim KM, et al. (2010). Mucinous gastric cancer presents with more advanced tumor stage and weaker beta-catenin expression than nonmucinous cancer. Ann. Surg. Oncol. 17: 3053-3058.
http://dx.doi.org/10.1245/s10434-010-1184-z
PMid:20645013
Davidson B, Zhang Z, Kleinberg L, Li M, et al. (2006). Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma. Clin. Cancer Res. 12: 5944-5950.
http://dx.doi.org/10.1158/1078-0432.CCR-06-1059
PMid:17062665
Hippo Y, Yashiro M, Ishii M, Taniguchi H, et al. (2001). Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res. 61: 889-895.
PMid:11221876
Huerta S, Harris DM, Jazirehi A, Bonavida B, et al. (2003). Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int. J. Oncol. 22: 663-670.
PMid:12579322
Jemal A, Murray T, Ward E, Samuels A, et al. (2005). Cancer statistics, 2005. CA Cancer J. Clin. 55: 10-30.
http://dx.doi.org/10.3322/canjclin.55.1.10
PMid:15661684
Kang YH, Lee HS and Kim WH (2002). Promoter methylation and silencing of PTEN in gastric carcinoma. Lab. Invest. 82: 285-291.
http://dx.doi.org/10.1038/labinvest.3780422
PMid:11896207
Lazăr D, Raica M, Sporea I, Tăban S, et al. (2006). Tumor angiogenesis in gastric cancer. Rom. J. Morphol. Embryol. 47: 5-13.
PMid:16838051
Lee SS, Jeong HE, Liu KH, Ryu JY, et al. (2005). Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity. Pharmacogenet. Genomics 15: 105-113.
http://dx.doi.org/10.1097/01213011-200502000-00006
PMid:15861034
Li DW, Wu Q, Peng ZH, Yang ZR, et al. (2007). Expression and significance of Notch1 and PTEN in gastric cancer. Ai Zheng 26: 1183-1187.
PMid:17991315
Li J, Wu Y, Qian X and Sha B (2006). Crystal structure of yeast Sis1 peptide-binding fragment and Hsp70 Ssa1 C-terminal complex. Biochem. J. 398: 353-360.
http://dx.doi.org/10.1042/BJ20060618
PMid:16737444 PMCid:1559466
Mori K, Aoyagi K, Ueda T, Danjoh I, et al. (2004). Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem. Biophys. Res. Commun. 313: 931-937.
http://dx.doi.org/10.1016/j.bbrc.2003.12.025
PMid:14706632
Motoori M, Takemasa I, Doki Y, Saito S, et al. (2006). Prediction of peritoneal metastasis in advanced gastric cancer by gene expression profiling of the primary site. Eur. J. Cancer 42: 1897-1903.
http://dx.doi.org/10.1016/j.ejca.2006.04.007
PMid:16831544
Ong CK, Ng CY, Leong C, Ng CP, et al. (2004). Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J. Biol. Chem. 279: 743-754.
http://dx.doi.org/10.1074/jbc.M308668200
PMid:14570898
Retterspitz MF, Monig SP, Schreckenberg S, Schneider PM, et al. (2010). Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis. Anticancer Res. 30: 4635-4641.
PMid:21115917
Schena M, Shalon D, Davis RW and Brown PO (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470.
http://dx.doi.org/10.1126/science.270.5235.467
PMid:7569999
Schieren G, Rumberger B, Klein M, Kreutz C, et al. (2006). Gene profiling of polycystic kidneys. Nephrol. Dial. Transplant 21: 1816-1824.
http://dx.doi.org/10.1093/ndt/gfl071
PMid:16520345
Shapira M, Ben-Izhak O, Bishara B, Futerman B, et al. (2004). Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Cancer 100: 1615-1621.
http://dx.doi.org/10.1002/cncr.20172
PMid:15073847
Wang J, Wu K, Bai F, Zhai H, et al. (2006). Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer. Cancer Lett. 242: 20-27.
http://dx.doi.org/10.1016/j.canlet.2005.10.030
PMid:16338068
Wang YY, Ye ZY, Zhao ZS, Tao HQ, et al. (2010). High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann. Surg. Oncol. 17: 89-97.
http://dx.doi.org/10.1245/s10434-009-0722-z
PMid:19820999
Yanagihara K, Takigahira M, Tanaka H, Komatsu T, et al. (2005). Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci. 96: 323-332.
http://dx.doi.org/10.1111/j.1349-7006.2005.00054.x
PMid:15958054
Yonemura Y, Endou Y, Kimura K, Fushida S, et al. (2000). Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin. Cancer Res. 6: 4234-4242.
PMid:11106237
Yonemura Y, Endo Y, Obata T and Sasaki T (2007). Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites. Cancer Sci. 98: 11-18.
http://dx.doi.org/10.1111/j.1349-7006.2006.00350.x
PMid:17052255
Yoon CS, Hyung WJ, Lee JH, Chae YS, et al. (2008). Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma. Hepatogastroenterology 55: 1916-1920.
PMid:19102422
Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, et al. (2006). Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer. Hepatogastroenterology 53: 964-967.
PMid:17153464